Loading…

Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa

Abstract Background Social anxiety disorder (SAD) is among the most common of all psychiatric disorders with lifetime prevalence estimates ranging from 7% to 13%. Although there is evidence that SAD has a strong familial basis, there are few studies of potential candidate genes. In addition to a gen...

Full description

Saved in:
Bibliographic Details
Published in:European neuropsychopharmacology 2007-04, Vol.17 (5), p.321-327
Main Authors: Lochner, Christine, Hemmings, Sian, Seedat, Soraya, Kinnear, Craig, Schoeman, Renata, Annerbrink, Kristina, Olsson, Marie, Eriksson, Elias, Moolman-Smook, Johanna, Allgulander, Christer, Stein, Dan J
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c548t-d8d026e923b9cc3c6707ec0b7fe1b466f6208034a33260e44ba7cc5d6ec49083
cites
container_end_page 327
container_issue 5
container_start_page 321
container_title European neuropsychopharmacology
container_volume 17
creator Lochner, Christine
Hemmings, Sian
Seedat, Soraya
Kinnear, Craig
Schoeman, Renata
Annerbrink, Kristina
Olsson, Marie
Eriksson, Elias
Moolman-Smook, Johanna
Allgulander, Christer
Stein, Dan J
description Abstract Background Social anxiety disorder (SAD) is among the most common of all psychiatric disorders with lifetime prevalence estimates ranging from 7% to 13%. Although there is evidence that SAD has a strong familial basis, there are few studies of potential candidate genes. In addition to a genetic association, there is also the possibility that temperamental risk factors for the disorder may be genetically transmitted. Against this background, our aims were threefold: i.) to compare patients and controls with respect to personality traits, ii.) to genotype a subgroup of these participants to investigate the role of genes encoding components of serotonergic ( 5-HT ) and dopaminergic ( DA ) pathways in patients with SAD and iii.) to compare differences in temperament dimensions between carriers of different (dominant vs. recessive) alleles for selected polymorphisms in SAD patients. Methods Sixty-three patients ( n = 63; 35 male, 28 female) with a DSM-IV diagnosis of generalized SAD and SPIN-scores > 18, and age-matched control participants ( n = 150; 31 male, 119 female) were included in the study. The Temperament and Character Inventory (TCI) was used to measure behaviours associated with specific personality dimensions (i.e. temperament/character). DNA was extracted and genotyped to investigate the role of select candidate genes encoding components in serotonergic and dopaminergic pathways in mediating the development of SAD. To achieve this, the frequency of variants in 5-HT and DA genes was compared between a Caucasian subset of SAD patients ( n = 41) and a convenience sample of Caucasian controls ( n = 88), using case-control association analyses. We also investigated the frequency of variants in 5-HT and DA -related genes across temperament characteristics in SAD patients, using analyses of variance (ANOVA). Results Patients scored significantly higher on harm avoidance ( p < 0.001) but lower on novelty seeking ( p = 0.04) and self-directedness ( p = 0.004) compared to controls. In the Caucasian subset, there was a difference between patients and controls in distribution of the 5-HT 2A T102C polymorphism, with significantly more patients harboring T -containing genotypes ( T -containing genotypes: [ T / T + T / C ] vs. [ C / C ]) ( χ2 = 7.55; p = 0.012). Temperament dimensions did not, however, differ significantly between carriers of different (dominant vs. recessive) alleles for the 5-HT 2A T102C polymorphism in SAD patients. Conclusions The r
doi_str_mv 10.1016/j.euroneuro.2006.06.010
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_574421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X06001283</els_id><sourcerecordid>70228059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c548t-d8d026e923b9cc3c6707ec0b7fe1b466f6208034a33260e44ba7cc5d6ec49083</originalsourceid><addsrcrecordid>eNqNkkFv1DAQhS0EokvhL0BOnMgythM74YC0qqAgVeLQHrhZjj0p3mbjYDst--9x2KWVkCohjezR6HtvDvMIeUNhTYGK99s1zsGPy7NmAGK9FIUnZEUbyUvZCPaUrKBlVdlK-f2EvIhxC0Brztvn5ISKpm15Xa3IeI4jJmdioUdbTBiiH_Xg0r5IQbsUCzcWk04Ox9zfufSjiN44PWT8l8OMWRd9sBg-FJvC6Iil8WMKfihimu1-kV_6Ocs2fXBGvyTPej1EfHX8T8nV509XZ1_Ki2_nX882F6WpqyaVtrHABLaMd60x3AgJEg10skfaVUL0gkEDvNKcMwFYVZ2WxtRWoKlaaPgpKQ-28Q6nuVNTcDsd9sprp46jm9yhqmVVMZr55lF-Ct4-iP4KKWUtCC6y9N2j0ut5Unl0Pf9ZVdeizfjbA55tf84Yk9q5aHAY9Ih-jkoCYw3UCygPoAk-xoD9vTMFtWRAbdV9BtSSAbUUhax8fVwxdzu0D7rj0TOwOQCYL3DrMKho8oENWhfQJGW9-48lH__xMIMb84WHG9xj3Po55BxFRVVkCtTlEsUliSByClnD-W-5i-Bp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70228059</pqid></control><display><type>article</type><title>Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa</title><source>Elsevier</source><creator>Lochner, Christine ; Hemmings, Sian ; Seedat, Soraya ; Kinnear, Craig ; Schoeman, Renata ; Annerbrink, Kristina ; Olsson, Marie ; Eriksson, Elias ; Moolman-Smook, Johanna ; Allgulander, Christer ; Stein, Dan J</creator><creatorcontrib>Lochner, Christine ; Hemmings, Sian ; Seedat, Soraya ; Kinnear, Craig ; Schoeman, Renata ; Annerbrink, Kristina ; Olsson, Marie ; Eriksson, Elias ; Moolman-Smook, Johanna ; Allgulander, Christer ; Stein, Dan J</creatorcontrib><description>Abstract Background Social anxiety disorder (SAD) is among the most common of all psychiatric disorders with lifetime prevalence estimates ranging from 7% to 13%. Although there is evidence that SAD has a strong familial basis, there are few studies of potential candidate genes. In addition to a genetic association, there is also the possibility that temperamental risk factors for the disorder may be genetically transmitted. Against this background, our aims were threefold: i.) to compare patients and controls with respect to personality traits, ii.) to genotype a subgroup of these participants to investigate the role of genes encoding components of serotonergic ( 5-HT ) and dopaminergic ( DA ) pathways in patients with SAD and iii.) to compare differences in temperament dimensions between carriers of different (dominant vs. recessive) alleles for selected polymorphisms in SAD patients. Methods Sixty-three patients ( n = 63; 35 male, 28 female) with a DSM-IV diagnosis of generalized SAD and SPIN-scores &gt; 18, and age-matched control participants ( n = 150; 31 male, 119 female) were included in the study. The Temperament and Character Inventory (TCI) was used to measure behaviours associated with specific personality dimensions (i.e. temperament/character). DNA was extracted and genotyped to investigate the role of select candidate genes encoding components in serotonergic and dopaminergic pathways in mediating the development of SAD. To achieve this, the frequency of variants in 5-HT and DA genes was compared between a Caucasian subset of SAD patients ( n = 41) and a convenience sample of Caucasian controls ( n = 88), using case-control association analyses. We also investigated the frequency of variants in 5-HT and DA -related genes across temperament characteristics in SAD patients, using analyses of variance (ANOVA). Results Patients scored significantly higher on harm avoidance ( p &lt; 0.001) but lower on novelty seeking ( p = 0.04) and self-directedness ( p = 0.004) compared to controls. In the Caucasian subset, there was a difference between patients and controls in distribution of the 5-HT 2A T102C polymorphism, with significantly more patients harboring T -containing genotypes ( T -containing genotypes: [ T / T + T / C ] vs. [ C / C ]) ( χ2 = 7.55; p = 0.012). Temperament dimensions did not, however, differ significantly between carriers of different (dominant vs. recessive) alleles for the 5-HT 2A T102C polymorphism in SAD patients. Conclusions The results suggest a possible role for the 5-HT 2A T102C polymorphism in the development of SAD. To date genetic findings in SAD have been inconsistent; nevertheless, serotonergic variants, and their associations with temperaments (e.g. reward dependence) deserve further exploration, in the hope that endophenotypes relevant to SAD can ultimately be delineated.</description><identifier>ISSN: 0924-977X</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/j.euroneuro.2006.06.010</identifier><identifier>PMID: 16899354</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>5-HT2A ; Adolescent ; Adult ; Case-Control Studies ; Chi-Square Distribution ; Comorbidity ; Dopamine ; Dopamine Plasma Membrane Transport Proteins ; Dopamine Plasma Membrane Transport Proteins - genetics ; epidemiology ; Female ; Fysiologi ; Genetic ; Genetics ; Genotype ; Humans ; Internal Medicine ; Male ; Medicin och hälsovetenskap ; Middle Aged ; Personality ; Personality Inventory ; Phobic Disorders ; Phobic Disorders - epidemiology ; Phobic Disorders - genetics ; Phobic Disorders - physiopathology ; Phobic Disorders - psychology ; Physiology ; physiopathology ; Polymorphism ; Polymorphism, Genetic ; Psychiatry ; psychology ; Receptor ; Receptor, Serotonin, 5-HT2A - genetics ; Serotonin ; Social anxiety disorder ; South Africa ; South Africa - epidemiology ; Temperament</subject><ispartof>European neuropsychopharmacology, 2007-04, Vol.17 (5), p.321-327</ispartof><rights>Elsevier B.V. and ECNP</rights><rights>2006 Elsevier B.V. and ECNP</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c548t-d8d026e923b9cc3c6707ec0b7fe1b466f6208034a33260e44ba7cc5d6ec49083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16899354$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/55569$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:11290636$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Lochner, Christine</creatorcontrib><creatorcontrib>Hemmings, Sian</creatorcontrib><creatorcontrib>Seedat, Soraya</creatorcontrib><creatorcontrib>Kinnear, Craig</creatorcontrib><creatorcontrib>Schoeman, Renata</creatorcontrib><creatorcontrib>Annerbrink, Kristina</creatorcontrib><creatorcontrib>Olsson, Marie</creatorcontrib><creatorcontrib>Eriksson, Elias</creatorcontrib><creatorcontrib>Moolman-Smook, Johanna</creatorcontrib><creatorcontrib>Allgulander, Christer</creatorcontrib><creatorcontrib>Stein, Dan J</creatorcontrib><title>Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa</title><title>European neuropsychopharmacology</title><addtitle>Eur Neuropsychopharmacol</addtitle><description>Abstract Background Social anxiety disorder (SAD) is among the most common of all psychiatric disorders with lifetime prevalence estimates ranging from 7% to 13%. Although there is evidence that SAD has a strong familial basis, there are few studies of potential candidate genes. In addition to a genetic association, there is also the possibility that temperamental risk factors for the disorder may be genetically transmitted. Against this background, our aims were threefold: i.) to compare patients and controls with respect to personality traits, ii.) to genotype a subgroup of these participants to investigate the role of genes encoding components of serotonergic ( 5-HT ) and dopaminergic ( DA ) pathways in patients with SAD and iii.) to compare differences in temperament dimensions between carriers of different (dominant vs. recessive) alleles for selected polymorphisms in SAD patients. Methods Sixty-three patients ( n = 63; 35 male, 28 female) with a DSM-IV diagnosis of generalized SAD and SPIN-scores &gt; 18, and age-matched control participants ( n = 150; 31 male, 119 female) were included in the study. The Temperament and Character Inventory (TCI) was used to measure behaviours associated with specific personality dimensions (i.e. temperament/character). DNA was extracted and genotyped to investigate the role of select candidate genes encoding components in serotonergic and dopaminergic pathways in mediating the development of SAD. To achieve this, the frequency of variants in 5-HT and DA genes was compared between a Caucasian subset of SAD patients ( n = 41) and a convenience sample of Caucasian controls ( n = 88), using case-control association analyses. We also investigated the frequency of variants in 5-HT and DA -related genes across temperament characteristics in SAD patients, using analyses of variance (ANOVA). Results Patients scored significantly higher on harm avoidance ( p &lt; 0.001) but lower on novelty seeking ( p = 0.04) and self-directedness ( p = 0.004) compared to controls. In the Caucasian subset, there was a difference between patients and controls in distribution of the 5-HT 2A T102C polymorphism, with significantly more patients harboring T -containing genotypes ( T -containing genotypes: [ T / T + T / C ] vs. [ C / C ]) ( χ2 = 7.55; p = 0.012). Temperament dimensions did not, however, differ significantly between carriers of different (dominant vs. recessive) alleles for the 5-HT 2A T102C polymorphism in SAD patients. Conclusions The results suggest a possible role for the 5-HT 2A T102C polymorphism in the development of SAD. To date genetic findings in SAD have been inconsistent; nevertheless, serotonergic variants, and their associations with temperaments (e.g. reward dependence) deserve further exploration, in the hope that endophenotypes relevant to SAD can ultimately be delineated.</description><subject>5-HT2A</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Case-Control Studies</subject><subject>Chi-Square Distribution</subject><subject>Comorbidity</subject><subject>Dopamine</subject><subject>Dopamine Plasma Membrane Transport Proteins</subject><subject>Dopamine Plasma Membrane Transport Proteins - genetics</subject><subject>epidemiology</subject><subject>Female</subject><subject>Fysiologi</subject><subject>Genetic</subject><subject>Genetics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medicin och hälsovetenskap</subject><subject>Middle Aged</subject><subject>Personality</subject><subject>Personality Inventory</subject><subject>Phobic Disorders</subject><subject>Phobic Disorders - epidemiology</subject><subject>Phobic Disorders - genetics</subject><subject>Phobic Disorders - physiopathology</subject><subject>Phobic Disorders - psychology</subject><subject>Physiology</subject><subject>physiopathology</subject><subject>Polymorphism</subject><subject>Polymorphism, Genetic</subject><subject>Psychiatry</subject><subject>psychology</subject><subject>Receptor</subject><subject>Receptor, Serotonin, 5-HT2A - genetics</subject><subject>Serotonin</subject><subject>Social anxiety disorder</subject><subject>South Africa</subject><subject>South Africa - epidemiology</subject><subject>Temperament</subject><issn>0924-977X</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNkkFv1DAQhS0EokvhL0BOnMgythM74YC0qqAgVeLQHrhZjj0p3mbjYDst--9x2KWVkCohjezR6HtvDvMIeUNhTYGK99s1zsGPy7NmAGK9FIUnZEUbyUvZCPaUrKBlVdlK-f2EvIhxC0Brztvn5ISKpm15Xa3IeI4jJmdioUdbTBiiH_Xg0r5IQbsUCzcWk04Ox9zfufSjiN44PWT8l8OMWRd9sBg-FJvC6Iil8WMKfihimu1-kV_6Ocs2fXBGvyTPej1EfHX8T8nV509XZ1_Ki2_nX882F6WpqyaVtrHABLaMd60x3AgJEg10skfaVUL0gkEDvNKcMwFYVZ2WxtRWoKlaaPgpKQ-28Q6nuVNTcDsd9sprp46jm9yhqmVVMZr55lF-Ct4-iP4KKWUtCC6y9N2j0ut5Unl0Pf9ZVdeizfjbA55tf84Yk9q5aHAY9Ih-jkoCYw3UCygPoAk-xoD9vTMFtWRAbdV9BtSSAbUUhax8fVwxdzu0D7rj0TOwOQCYL3DrMKho8oENWhfQJGW9-48lH__xMIMb84WHG9xj3Po55BxFRVVkCtTlEsUliSByClnD-W-5i-Bp</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Lochner, Christine</creator><creator>Hemmings, Sian</creator><creator>Seedat, Soraya</creator><creator>Kinnear, Craig</creator><creator>Schoeman, Renata</creator><creator>Annerbrink, Kristina</creator><creator>Olsson, Marie</creator><creator>Eriksson, Elias</creator><creator>Moolman-Smook, Johanna</creator><creator>Allgulander, Christer</creator><creator>Stein, Dan J</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>F1U</scope></search><sort><creationdate>20070401</creationdate><title>Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa</title><author>Lochner, Christine ; Hemmings, Sian ; Seedat, Soraya ; Kinnear, Craig ; Schoeman, Renata ; Annerbrink, Kristina ; Olsson, Marie ; Eriksson, Elias ; Moolman-Smook, Johanna ; Allgulander, Christer ; Stein, Dan J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c548t-d8d026e923b9cc3c6707ec0b7fe1b466f6208034a33260e44ba7cc5d6ec49083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>5-HT2A</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Case-Control Studies</topic><topic>Chi-Square Distribution</topic><topic>Comorbidity</topic><topic>Dopamine</topic><topic>Dopamine Plasma Membrane Transport Proteins</topic><topic>Dopamine Plasma Membrane Transport Proteins - genetics</topic><topic>epidemiology</topic><topic>Female</topic><topic>Fysiologi</topic><topic>Genetic</topic><topic>Genetics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medicin och hälsovetenskap</topic><topic>Middle Aged</topic><topic>Personality</topic><topic>Personality Inventory</topic><topic>Phobic Disorders</topic><topic>Phobic Disorders - epidemiology</topic><topic>Phobic Disorders - genetics</topic><topic>Phobic Disorders - physiopathology</topic><topic>Phobic Disorders - psychology</topic><topic>Physiology</topic><topic>physiopathology</topic><topic>Polymorphism</topic><topic>Polymorphism, Genetic</topic><topic>Psychiatry</topic><topic>psychology</topic><topic>Receptor</topic><topic>Receptor, Serotonin, 5-HT2A - genetics</topic><topic>Serotonin</topic><topic>Social anxiety disorder</topic><topic>South Africa</topic><topic>South Africa - epidemiology</topic><topic>Temperament</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lochner, Christine</creatorcontrib><creatorcontrib>Hemmings, Sian</creatorcontrib><creatorcontrib>Seedat, Soraya</creatorcontrib><creatorcontrib>Kinnear, Craig</creatorcontrib><creatorcontrib>Schoeman, Renata</creatorcontrib><creatorcontrib>Annerbrink, Kristina</creatorcontrib><creatorcontrib>Olsson, Marie</creatorcontrib><creatorcontrib>Eriksson, Elias</creatorcontrib><creatorcontrib>Moolman-Smook, Johanna</creatorcontrib><creatorcontrib>Allgulander, Christer</creatorcontrib><creatorcontrib>Stein, Dan J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Göteborgs universitet</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lochner, Christine</au><au>Hemmings, Sian</au><au>Seedat, Soraya</au><au>Kinnear, Craig</au><au>Schoeman, Renata</au><au>Annerbrink, Kristina</au><au>Olsson, Marie</au><au>Eriksson, Elias</au><au>Moolman-Smook, Johanna</au><au>Allgulander, Christer</au><au>Stein, Dan J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa</atitle><jtitle>European neuropsychopharmacology</jtitle><addtitle>Eur Neuropsychopharmacol</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>17</volume><issue>5</issue><spage>321</spage><epage>327</epage><pages>321-327</pages><issn>0924-977X</issn><eissn>1873-7862</eissn><abstract>Abstract Background Social anxiety disorder (SAD) is among the most common of all psychiatric disorders with lifetime prevalence estimates ranging from 7% to 13%. Although there is evidence that SAD has a strong familial basis, there are few studies of potential candidate genes. In addition to a genetic association, there is also the possibility that temperamental risk factors for the disorder may be genetically transmitted. Against this background, our aims were threefold: i.) to compare patients and controls with respect to personality traits, ii.) to genotype a subgroup of these participants to investigate the role of genes encoding components of serotonergic ( 5-HT ) and dopaminergic ( DA ) pathways in patients with SAD and iii.) to compare differences in temperament dimensions between carriers of different (dominant vs. recessive) alleles for selected polymorphisms in SAD patients. Methods Sixty-three patients ( n = 63; 35 male, 28 female) with a DSM-IV diagnosis of generalized SAD and SPIN-scores &gt; 18, and age-matched control participants ( n = 150; 31 male, 119 female) were included in the study. The Temperament and Character Inventory (TCI) was used to measure behaviours associated with specific personality dimensions (i.e. temperament/character). DNA was extracted and genotyped to investigate the role of select candidate genes encoding components in serotonergic and dopaminergic pathways in mediating the development of SAD. To achieve this, the frequency of variants in 5-HT and DA genes was compared between a Caucasian subset of SAD patients ( n = 41) and a convenience sample of Caucasian controls ( n = 88), using case-control association analyses. We also investigated the frequency of variants in 5-HT and DA -related genes across temperament characteristics in SAD patients, using analyses of variance (ANOVA). Results Patients scored significantly higher on harm avoidance ( p &lt; 0.001) but lower on novelty seeking ( p = 0.04) and self-directedness ( p = 0.004) compared to controls. In the Caucasian subset, there was a difference between patients and controls in distribution of the 5-HT 2A T102C polymorphism, with significantly more patients harboring T -containing genotypes ( T -containing genotypes: [ T / T + T / C ] vs. [ C / C ]) ( χ2 = 7.55; p = 0.012). Temperament dimensions did not, however, differ significantly between carriers of different (dominant vs. recessive) alleles for the 5-HT 2A T102C polymorphism in SAD patients. Conclusions The results suggest a possible role for the 5-HT 2A T102C polymorphism in the development of SAD. To date genetic findings in SAD have been inconsistent; nevertheless, serotonergic variants, and their associations with temperaments (e.g. reward dependence) deserve further exploration, in the hope that endophenotypes relevant to SAD can ultimately be delineated.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>16899354</pmid><doi>10.1016/j.euroneuro.2006.06.010</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0924-977X
ispartof European neuropsychopharmacology, 2007-04, Vol.17 (5), p.321-327
issn 0924-977X
1873-7862
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_574421
source Elsevier
subjects 5-HT2A
Adolescent
Adult
Case-Control Studies
Chi-Square Distribution
Comorbidity
Dopamine
Dopamine Plasma Membrane Transport Proteins
Dopamine Plasma Membrane Transport Proteins - genetics
epidemiology
Female
Fysiologi
Genetic
Genetics
Genotype
Humans
Internal Medicine
Male
Medicin och hälsovetenskap
Middle Aged
Personality
Personality Inventory
Phobic Disorders
Phobic Disorders - epidemiology
Phobic Disorders - genetics
Phobic Disorders - physiopathology
Phobic Disorders - psychology
Physiology
physiopathology
Polymorphism
Polymorphism, Genetic
Psychiatry
psychology
Receptor
Receptor, Serotonin, 5-HT2A - genetics
Serotonin
Social anxiety disorder
South Africa
South Africa - epidemiology
Temperament
title Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T19%3A40%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetics%20and%20personality%20traits%20in%20patients%20with%20social%20anxiety%20disorder:%20A%20case-control%20study%20in%20South%20Africa&rft.jtitle=European%20neuropsychopharmacology&rft.au=Lochner,%20Christine&rft.date=2007-04-01&rft.volume=17&rft.issue=5&rft.spage=321&rft.epage=327&rft.pages=321-327&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/j.euroneuro.2006.06.010&rft_dat=%3Cproquest_swepu%3E70228059%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c548t-d8d026e923b9cc3c6707ec0b7fe1b466f6208034a33260e44ba7cc5d6ec49083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70228059&rft_id=info:pmid/16899354&rfr_iscdi=true